• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.芬兰南部一组患者中化脓性汗腺炎的负担:一项试点研究。
Skin Appendage Disord. 2017 Mar;3(1):20-27. doi: 10.1159/000455236. Epub 2017 Jan 12.
2
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
3
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.化脓性汗腺炎改良 Hurley 分级与患者报告的生活质量和客观疾病严重程度评估的相关性。
Br J Dermatol. 2019 May;180(5):1214-1220. doi: 10.1111/bjd.17508. Epub 2019 Feb 25.
4
Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis.用15D工具测量化脓性汗腺炎患者的健康相关生活质量并与普通人群和银屑病患者进行比较。
Skin Appendage Disord. 2018 Aug;4(3):131-135. doi: 10.1159/000481117. Epub 2017 Oct 4.
5
Factors affecting quality of life in patients with hidradenitis suppurativa.影响化脓性汗腺炎患者生活质量的因素。
Arch Dermatol Res. 2020 Aug;312(6):427-436. doi: 10.1007/s00403-019-02025-5. Epub 2019 Dec 17.
6
Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.化脓性汗腺炎患者的生活质量损害:一项对1795例患者的横断面研究。
Life (Basel). 2021 Jan 8;11(1):34. doi: 10.3390/life11010034.
7
The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.恶臭对化脓性汗腺炎患者生活质量的影响。
J Cutan Med Surg. 2018 Mar/Apr;22(2):166-174. doi: 10.1177/1203475417745826. Epub 2017 Dec 12.
8
Assessing the psychological burden of patients with hidradenitis suppurativa.评估化脓性汗腺炎患者的心理负担。
Eur J Dermatol. 2019 Jun 1;29(3):294-301. doi: 10.1684/ejd.2019.3552.
9
Internalized Stigma in Hidradenitis Suppurativa: A Multicenter Cross-Sectional Study.化脓性汗腺炎患者的内化污名:一项多中心横断面研究。
Dermatology. 2023;239(3):445-453. doi: 10.1159/000529194. Epub 2023 Jan 26.
10
Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?自我报告的化脓性汗腺炎严重程度:对临床实践有用吗?
Dermatol Ther (Heidelb). 2022 Apr;12(4):899-909. doi: 10.1007/s13555-022-00701-5. Epub 2022 Mar 10.

引用本文的文献

1
Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.探究化脓性汗腺炎患者疾病历程中的种族和民族差异:欧洲和美国一项真实世界研究的结果
J Dermatol. 2024 Dec;51(12):1547-1558. doi: 10.1111/1346-8138.17386. Epub 2024 Oct 14.
2
Global Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis.皮肤病患者焦虑、抑郁和压力的全球患病率:系统评价和荟萃分析。
J Prev (2022). 2024 Aug;45(4):611-649. doi: 10.1007/s10935-024-00784-0. Epub 2024 Jun 1.
3
Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects.芬兰北部出生队列 1986 年研究中的化脓性汗腺炎患病率和特征:一项 2775 名受试者的横断面研究。
Acta Derm Venereol. 2024 Jan 10;104:adv14732. doi: 10.2340/actadv.v104.14732.
4
Thyroid Diseases in a Cohort of Finnish Patients with Hidradenitis Suppurativa.一组芬兰化脓性汗腺炎患者的甲状腺疾病
Skin Appendage Disord. 2023 Jun;9(3):191-194. doi: 10.1159/000529907. Epub 2023 Apr 4.
5
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.化脓性汗腺炎体征和症状对生活质量的影响负担:系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Jun 22;18(13):6709. doi: 10.3390/ijerph18136709.
6
Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients.化脓性汗腺炎患者生活质量受损相关特征。
Front Med (Lausanne). 2021 Apr 27;8:676241. doi: 10.3389/fmed.2021.676241. eCollection 2021.
7
The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.中重度化脓性汗腺炎患者 EQ-5D-5L 与 EQ-5D-3L 的测量性能比较。
Qual Life Res. 2021 May;30(5):1477-1490. doi: 10.1007/s11136-020-02732-x. Epub 2021 Feb 3.
8
Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.化脓性汗腺炎患者的生活质量损害:一项对1795例患者的横断面研究。
Life (Basel). 2021 Jan 8;11(1):34. doi: 10.3390/life11010034.
9
Hidradenitis Suppurativa: An Asian Perspective from a Singaporean Institute.化脓性汗腺炎:新加坡一家机构的亚洲视角
Skin Appendage Disord. 2018 Oct;4(4):281-285. doi: 10.1159/000481836. Epub 2018 Jan 26.
10
Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis.用15D工具测量化脓性汗腺炎患者的健康相关生活质量并与普通人群和银屑病患者进行比较。
Skin Appendage Disord. 2018 Aug;4(3):131-135. doi: 10.1159/000481117. Epub 2017 Oct 4.

本文引用的文献

1
Pain in Hidradenitis Suppurativa: A Pilot Study.化脓性汗腺炎的疼痛:一项初步研究。
Acta Derm Venereol. 2016 May;96(4):554-6. doi: 10.2340/00015555-2308.
2
The Handicap of Hidradenitis Suppurativa.化脓性汗腺炎的障碍
Dermatol Clin. 2016 Jan;34(1):17-22. doi: 10.1016/j.det.2015.07.003. Epub 2015 Sep 14.
3
Hidradenitis suppurativa: Epidemiology and scope of the problem.化脓性汗腺炎:流行病学和问题范围。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7. doi: 10.1016/j.jaad.2015.07.052.
4
The psychosocial impact of hidradenitis suppurativa.化脓性汗腺炎的社会心理影响。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S19-22. doi: 10.1016/j.jaad.2015.07.054.
5
Clinical Features and Patient Outcomes of Hidradenitis Suppurativa: A Cross-Sectional Retrospective Study.化脓性汗腺炎的临床特征与患者预后:一项横断面回顾性研究
J Cutan Med Surg. 2016 Jan;20(1):52-7. doi: 10.1177/1203475415602840. Epub 2015 Aug 28.
6
Diagnostic delay in hidradenitis suppurativa is a global problem.化脓性汗腺炎的诊断延迟是一个全球性问题。
Br J Dermatol. 2015 Dec;173(6):1546-9. doi: 10.1111/bjd.14038. Epub 2015 Nov 3.
7
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.欧洲化脓性汗腺炎/反向性痤疮治疗S1指南。
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44. doi: 10.1111/jdv.12966. Epub 2015 Jan 30.
8
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.化脓性汗腺炎是一种系统性疾病,具有较大的合并症负担:基于图表验证的病例对照分析。
J Am Acad Dermatol. 2014 Dec;71(6):1144-50. doi: 10.1016/j.jaad.2014.09.012. Epub 2014 Oct 14.
9
Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.化脓性汗腺炎临床斯堪的纳维亚登记处(HISREG)的开发。
Acta Derm Venereol. 2013 May;93(3):350-1. doi: 10.2340/00015555-1468.
10
Painful hidradenitis suppurativa.疼痛性化脓性汗腺炎。
Clin J Pain. 2010 Jun;26(5):435-44. doi: 10.1097/AJP.0b013e3181ceb80c.

芬兰南部一组患者中化脓性汗腺炎的负担:一项试点研究。

The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.

作者信息

Kluger Nicolas, Ranta Martta, Serlachius Martina

机构信息

Department of Dermatology and Allergology, University of Helsinki, Espoo, Finland.

Department of Dermatology and Allergology, Helsinki University Central Hospital, Helsinki, Espoo, Finland.

出版信息

Skin Appendage Disord. 2017 Mar;3(1):20-27. doi: 10.1159/000455236. Epub 2017 Jan 12.

DOI:10.1159/000455236
PMID:28611997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5465670/
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a chronic inflammatory disease that impacts the quality of life.

METHODS

We evaluated its burden in a cohort of 26 Finnish patients in a single-center cross-sectional study. Demographic data, disease history, clinical data, treatment patterns, and workability were collected. Patients responded to the Dermatology Life Quality Index (DLQI) and Beck Depression Inventory (BDI-21).

RESULTS

Mean age of HS patients was 44.2 years and mean diagnostic delay was 13.7 years. Pain was rated the most bothersome symptom. Mean DLQI score was 8.31. Women consistently had higher scores than men for every item of the DLQI. Mean BDI-21 score was 10.69. Higher Hurley stage at visit ( = 0.001), female gender ( = 0.018), and higher BDI-21 score ( = 0.022) were variables that significantly affected the total DLQI score, whereas female gender ( = 0.004) was the only variable that significantly affected the total BDI-21 score using stepwise regression analysis.

CONCLUSIONS

The burden of HS is for the first time reported in Finland. The diagnostic delay is longer than previously reported and the results suggest that women are impacted by the disease more than men.

摘要

背景

化脓性汗腺炎(HS)是一种影响生活质量的慢性炎症性疾病。

方法

在一项单中心横断面研究中,我们评估了26名芬兰患者队列中的疾病负担。收集了人口统计学数据、疾病史、临床数据、治疗模式和工作能力等信息。患者对皮肤病生活质量指数(DLQI)和贝克抑郁量表(BDI - 21)进行了回应。

结果

HS患者的平均年龄为44.2岁,平均诊断延迟为13.7年。疼痛被评为最困扰的症状。DLQI平均得分为8.31。在DLQI的每个项目中,女性得分始终高于男性。BDI - 21平均得分为10.69。就诊时更高的Hurley分期(= 0.001)、女性性别(= 0.018)和更高的BDI - 21得分(= 0.022)是显著影响DLQI总分的变量,而使用逐步回归分析时,女性性别(= 0.004)是显著影响BDI - 21总分的唯一变量。

结论

芬兰首次报告了HS的疾病负担。诊断延迟比先前报告的更长,结果表明女性比男性受该疾病的影响更大。